Varian Receives FDA "Breakthrough Device Designation" For Embozene® Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Spoke,
PALO ALTO, Calif., Oct. 13, 2021 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the U.S.